248 related articles for article (PubMed ID: 29257214)
1. Icariin ameliorates dexamethasone‑induced bone deterioration in an experimental mouse model via activation of microRNA‑186 inhibition of cathepsin K.
Ma Y; Yang H; Huang J
Mol Med Rep; 2018 Jan; 17(1):1633-1641. PubMed ID: 29257214
[TBL] [Abstract][Full Text] [Related]
2. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R
Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838
[TBL] [Abstract][Full Text] [Related]
3. Icariin possesses chondroprotective efficacy in a rat model of dexamethasone-induced cartilage injury through the activation of miR-206 targeting of cathepsin K.
Liu N; Zhang T; Cao BR; Luan FY; Liu RX; Yin HR; Wang WB
Int J Mol Med; 2018 Feb; 41(2):1039-1047. PubMed ID: 29207029
[TBL] [Abstract][Full Text] [Related]
4. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
Yang Y; Nian H; Tang X; Wang X; Liu R
J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
[TBL] [Abstract][Full Text] [Related]
5. Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice.
Zhang J; Song J; Shao J
Int J Clin Exp Med; 2015; 8(5):7306-14. PubMed ID: 26221270
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis.
Sun P; Liu Y; Deng X; Yu C; Dai N; Yuan X; Chen L; Yu S; Si W; Wang X; Wu D; Liu S; Pang H
Phytomedicine; 2013 Aug; 20(11):975-9. PubMed ID: 23746958
[TBL] [Abstract][Full Text] [Related]
7. Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo.
Feng R; Feng L; Yuan Z; Wang D; Wang F; Tan B; Han S; Li T; Li D; Han Y
Cell Biochem Biophys; 2013 Sep; 67(1):189-97. PubMed ID: 23417569
[TBL] [Abstract][Full Text] [Related]
8. Aqueous extract of pomegranate seed attenuates glucocorticoid-induced bone loss and hypercalciuria in mice: A comparative study with alendronate.
Zhang Y; Shao J; Wang Z; Yang T; Liu S; Liu Y; Fan X; Ye W
Int J Mol Med; 2016 Aug; 38(2):491-8. PubMed ID: 27278225
[TBL] [Abstract][Full Text] [Related]
9. Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice.
Cheng Y; Wang WL; Liang JJ
Int J Clin Exp Pathol; 2015; 8(1):394-403. PubMed ID: 25755727
[TBL] [Abstract][Full Text] [Related]
10. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine.
Ren H; Shen G; Tang J; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Liang D; Yao Z; Yang Z; Jiang X
Sci Rep; 2017 Sep; 7(1):10617. PubMed ID: 28878388
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis.
Yongtao Z; Kunzheng W; Jingjing Z; Hu S; Jianqiang K; Ruiyu L; Chunsheng W
Endocrine; 2014 Nov; 47(2):598-608. PubMed ID: 24519760
[TBL] [Abstract][Full Text] [Related]
13. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
[TBL] [Abstract][Full Text] [Related]
14. Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.
Stone JA; McCrea JB; Witter R; Zajic S; Stoch SA
Br J Clin Pharmacol; 2019 Jun; 85(6):1072-1083. PubMed ID: 30663085
[TBL] [Abstract][Full Text] [Related]
15. JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice.
Guo Y; Wang L; Ma R; Mu Q; Yu N; Zhang Y; Tang Y; Li Y; Jiang G; Zhao D; Mo F; Gao S; Yang M; Kan F; Ma Q; Fu M; Zhang D
Life Sci; 2016 Mar; 148():24-30. PubMed ID: 26892148
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis.
Yin M; Zhou D; Jia F; Su X; Li X; Sun R; Li J
J Orthop Surg Res; 2023 Jun; 18(1):409. PubMed ID: 37277810
[TBL] [Abstract][Full Text] [Related]
17. [Reducing bone resorption by cathepsin K inhibitor and treatment of osteoporosis].
Watanabe R; Okazaki R
Clin Calcium; 2014 Jan; 24(1):59-67. PubMed ID: 24369281
[TBL] [Abstract][Full Text] [Related]
18. Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis.
Sun X; Wei J; Lyu J; Bian T; Liu Z; Huang J; Pi F; Li C; Zhong Z
J Nanobiotechnology; 2019 Jan; 17(1):10. PubMed ID: 30670021
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
Mukherjee K; Chattopadhyay N
Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
[TBL] [Abstract][Full Text] [Related]
20. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption.
Zhang Y; Li Q; Li X; Wan HY; Wong MS
Br J Nutr; 2010 Oct; 104(7):965-71. PubMed ID: 20487580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
